EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.1.1.137 | Atherosclerosis |
21605854 |
Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
1
0 |
| 2.1.1.137 | Atherosclerosis |
28728140 |
Effects of Inorganic Arsenic, Methylated Arsenicals, and Arsenobetaine on Atherosclerosis in the Mouse Model and the Role of As3mt-Mediated Methylation. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
3
1 |
| 2.1.1.137 | Atherosclerosis |
29874848 |
Ethnic, Geographic, and Genetic Differences in Arsenic Metabolism at Low Arsenic Exposure: A Preliminary Analysis in the Multi-Ethnic Study of Atherosclerosis (MESA). |
ongoing research
unassigned |
3
0 |
| 2.1.1.137 | Carcinogenesis |
16407288 |
Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.1.1.137 | Carcinogenesis |
17850829 |
Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 2.1.1.137 | Carcinogenesis |
30017583 |
N6-Methyladenine DNA Modification in the Human Genome. |
diagnostic usage
unassigned |
2
0 |
| 2.1.1.137 | Carcinogenesis |
32930475 |
Inorganic arsenic-mediated upregulation of AS3MT promotes proliferation of nonsmall cell lung cancer cells by regulating cell cycle genes. |
causal interaction
therapeutic application
unassigned |
2
3
0 |
| 2.1.1.137 | Carcinogenesis |
32971865 |
Arsenic Methyltransferase and Methylation of Inorganic Arsenic. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.1.1.137 | Carcinoma |
25156000 |
Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.137 | Carcinoma, Basal Cell |
25156000 |
Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population. |
therapeutic application
unassigned |
1
0 |
